nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Abnormal vision—Progesterone—uterine cancer	0.0288	0.0288	CcSEcCtD
Metipranolol—Arthritis—Progesterone—uterine cancer	0.0247	0.0247	CcSEcCtD
Metipranolol—Angina pectoris—Progesterone—uterine cancer	0.0202	0.0202	CcSEcCtD
Metipranolol—Bronchitis—Progesterone—uterine cancer	0.0199	0.0199	CcSEcCtD
Metipranolol—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.0181	0.0181	CcSEcCtD
Metipranolol—Conjunctivitis—Progesterone—uterine cancer	0.018	0.018	CcSEcCtD
Metipranolol—Rhinitis—Progesterone—uterine cancer	0.0166	0.0166	CcSEcCtD
Metipranolol—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.0165	0.0165	CcSEcCtD
Metipranolol—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.0164	0.0164	CcSEcCtD
Metipranolol—Lacrimation—Epirubicin—uterine cancer	0.0161	0.0161	CcSEcCtD
Metipranolol—Visual impairment—Progesterone—uterine cancer	0.016	0.016	CcSEcCtD
Metipranolol—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.0158	0.0158	CcSEcCtD
Metipranolol—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.0153	0.0153	CcSEcCtD
Metipranolol—Lacrimation—Doxorubicin—uterine cancer	0.0149	0.0149	CcSEcCtD
Metipranolol—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.0145	0.0145	CcSEcCtD
Metipranolol—Tension—Progesterone—uterine cancer	0.0142	0.0142	CcSEcCtD
Metipranolol—Nervousness—Progesterone—uterine cancer	0.014	0.014	CcSEcCtD
Metipranolol—Vision blurred—Progesterone—uterine cancer	0.0136	0.0136	CcSEcCtD
Metipranolol—Tension—Medroxyprogesterone Acetate—uterine cancer	0.0129	0.0129	CcSEcCtD
Metipranolol—Palpitations—Progesterone—uterine cancer	0.0128	0.0128	CcSEcCtD
Metipranolol—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0127	CcSEcCtD
Metipranolol—Cough—Progesterone—uterine cancer	0.0126	0.0126	CcSEcCtD
Metipranolol—Hypertension—Progesterone—uterine cancer	0.0125	0.0125	CcSEcCtD
Metipranolol—Myalgia—Progesterone—uterine cancer	0.0123	0.0123	CcSEcCtD
Metipranolol—Anxiety—Progesterone—uterine cancer	0.0123	0.0123	CcSEcCtD
Metipranolol—Discomfort—Progesterone—uterine cancer	0.0122	0.0122	CcSEcCtD
Metipranolol—Oedema—Progesterone—uterine cancer	0.0118	0.0118	CcSEcCtD
Metipranolol—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.0116	0.0116	CcSEcCtD
Metipranolol—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0111	0.0111	CcSEcCtD
Metipranolol—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.0111	0.0111	CcSEcCtD
Metipranolol—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.011	0.011	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Progesterone—uterine cancer	0.0107	0.0107	CcSEcCtD
Metipranolol—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.0107	0.0107	CcSEcCtD
Metipranolol—Dyspnoea—Progesterone—uterine cancer	0.0105	0.0105	CcSEcCtD
Metipranolol—Somnolence—Progesterone—uterine cancer	0.0105	0.0105	CcSEcCtD
Metipranolol—Lacrimation increased—Epirubicin—uterine cancer	0.0103	0.0103	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00974	0.00974	CcSEcCtD
Metipranolol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00953	0.00953	CcSEcCtD
Metipranolol—Lacrimation increased—Doxorubicin—uterine cancer	0.00952	0.00952	CcSEcCtD
Metipranolol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.0095	0.0095	CcSEcCtD
Metipranolol—Acute coronary syndrome—Etoposide—uterine cancer	0.00933	0.00933	CcSEcCtD
Metipranolol—Myocardial infarction—Etoposide—uterine cancer	0.00927	0.00927	CcSEcCtD
Metipranolol—Myalgia—Dactinomycin—uterine cancer	0.0087	0.0087	CcSEcCtD
Metipranolol—Hypersensitivity—Progesterone—uterine cancer	0.00869	0.00869	CcSEcCtD
Metipranolol—Discomfort—Dactinomycin—uterine cancer	0.00859	0.00859	CcSEcCtD
Metipranolol—Asthenia—Progesterone—uterine cancer	0.00846	0.00846	CcSEcCtD
Metipranolol—Oedema—Dactinomycin—uterine cancer	0.00834	0.00834	CcSEcCtD
Metipranolol—Abnormal vision—Epirubicin—uterine cancer	0.00827	0.00827	CcSEcCtD
Metipranolol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00787	0.00787	CcSEcCtD
Metipranolol—Dizziness—Progesterone—uterine cancer	0.0078	0.0078	CcSEcCtD
Metipranolol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00767	0.00767	CcSEcCtD
Metipranolol—Abnormal vision—Doxorubicin—uterine cancer	0.00765	0.00765	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.0076	0.0076	CcSEcCtD
Metipranolol—Rash—Progesterone—uterine cancer	0.00744	0.00744	CcSEcCtD
Metipranolol—Dermatitis—Progesterone—uterine cancer	0.00743	0.00743	CcSEcCtD
Metipranolol—Headache—Progesterone—uterine cancer	0.00739	0.00739	CcSEcCtD
Metipranolol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00707	0.00707	CcSEcCtD
Metipranolol—Nausea—Progesterone—uterine cancer	0.00701	0.00701	CcSEcCtD
Metipranolol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00674	0.00674	CcSEcCtD
Metipranolol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00673	0.00673	CcSEcCtD
Metipranolol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0067	0.0067	CcSEcCtD
Metipranolol—Cough—Etoposide—uterine cancer	0.00645	0.00645	CcSEcCtD
Metipranolol—Hypertension—Etoposide—uterine cancer	0.00638	0.00638	CcSEcCtD
Metipranolol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00635	0.00635	CcSEcCtD
Metipranolol—Discomfort—Etoposide—uterine cancer	0.00622	0.00622	CcSEcCtD
Metipranolol—Hypersensitivity—Dactinomycin—uterine cancer	0.00614	0.00614	CcSEcCtD
Metipranolol—Asthenia—Dactinomycin—uterine cancer	0.00598	0.00598	CcSEcCtD
Metipranolol—Angina pectoris—Epirubicin—uterine cancer	0.00579	0.00579	CcSEcCtD
Metipranolol—Bronchitis—Epirubicin—uterine cancer	0.00572	0.00572	CcSEcCtD
Metipranolol—Dyspnoea—Etoposide—uterine cancer	0.00538	0.00538	CcSEcCtD
Metipranolol—Somnolence—Etoposide—uterine cancer	0.00536	0.00536	CcSEcCtD
Metipranolol—Angina pectoris—Doxorubicin—uterine cancer	0.00536	0.00536	CcSEcCtD
Metipranolol—Bronchitis—Doxorubicin—uterine cancer	0.00529	0.00529	CcSEcCtD
Metipranolol—Rash—Dactinomycin—uterine cancer	0.00526	0.00526	CcSEcCtD
Metipranolol—Conjunctivitis—Epirubicin—uterine cancer	0.00515	0.00515	CcSEcCtD
Metipranolol—Epistaxis—Epirubicin—uterine cancer	0.005	0.005	CcSEcCtD
Metipranolol—Nausea—Dactinomycin—uterine cancer	0.00495	0.00495	CcSEcCtD
Metipranolol—Bradycardia—Epirubicin—uterine cancer	0.00485	0.00485	CcSEcCtD
Metipranolol—Rhinitis—Epirubicin—uterine cancer	0.00477	0.00477	CcSEcCtD
Metipranolol—Conjunctivitis—Doxorubicin—uterine cancer	0.00477	0.00477	CcSEcCtD
Metipranolol—Epistaxis—Doxorubicin—uterine cancer	0.00463	0.00463	CcSEcCtD
Metipranolol—Visual impairment—Epirubicin—uterine cancer	0.00459	0.00459	CcSEcCtD
Metipranolol—Bradycardia—Doxorubicin—uterine cancer	0.00448	0.00448	CcSEcCtD
Metipranolol—Hypersensitivity—Etoposide—uterine cancer	0.00445	0.00445	CcSEcCtD
Metipranolol—Rhinitis—Doxorubicin—uterine cancer	0.00442	0.00442	CcSEcCtD
Metipranolol—Asthenia—Etoposide—uterine cancer	0.00433	0.00433	CcSEcCtD
Metipranolol—Visual impairment—Doxorubicin—uterine cancer	0.00425	0.00425	CcSEcCtD
Metipranolol—Tension—Epirubicin—uterine cancer	0.00407	0.00407	CcSEcCtD
Metipranolol—Nervousness—Epirubicin—uterine cancer	0.00403	0.00403	CcSEcCtD
Metipranolol—Dizziness—Etoposide—uterine cancer	0.00399	0.00399	CcSEcCtD
Metipranolol—Vision blurred—Epirubicin—uterine cancer	0.00391	0.00391	CcSEcCtD
Metipranolol—Rash—Etoposide—uterine cancer	0.0038	0.0038	CcSEcCtD
Metipranolol—Dermatitis—Etoposide—uterine cancer	0.0038	0.0038	CcSEcCtD
Metipranolol—Headache—Etoposide—uterine cancer	0.00378	0.00378	CcSEcCtD
Metipranolol—Tension—Doxorubicin—uterine cancer	0.00376	0.00376	CcSEcCtD
Metipranolol—Nervousness—Doxorubicin—uterine cancer	0.00372	0.00372	CcSEcCtD
Metipranolol—Palpitations—Epirubicin—uterine cancer	0.00366	0.00366	CcSEcCtD
Metipranolol—Cough—Epirubicin—uterine cancer	0.00362	0.00362	CcSEcCtD
Metipranolol—Vision blurred—Doxorubicin—uterine cancer	0.00361	0.00361	CcSEcCtD
Metipranolol—Nausea—Etoposide—uterine cancer	0.00358	0.00358	CcSEcCtD
Metipranolol—Hypertension—Epirubicin—uterine cancer	0.00358	0.00358	CcSEcCtD
Metipranolol—Myalgia—Epirubicin—uterine cancer	0.00353	0.00353	CcSEcCtD
Metipranolol—Anxiety—Epirubicin—uterine cancer	0.00352	0.00352	CcSEcCtD
Metipranolol—Discomfort—Epirubicin—uterine cancer	0.00349	0.00349	CcSEcCtD
Metipranolol—Palpitations—Doxorubicin—uterine cancer	0.00339	0.00339	CcSEcCtD
Metipranolol—Oedema—Epirubicin—uterine cancer	0.00338	0.00338	CcSEcCtD
Metipranolol—Cough—Doxorubicin—uterine cancer	0.00335	0.00335	CcSEcCtD
Metipranolol—Hypertension—Doxorubicin—uterine cancer	0.00331	0.00331	CcSEcCtD
Metipranolol—Myalgia—Doxorubicin—uterine cancer	0.00326	0.00326	CcSEcCtD
Metipranolol—Anxiety—Doxorubicin—uterine cancer	0.00325	0.00325	CcSEcCtD
Metipranolol—Discomfort—Doxorubicin—uterine cancer	0.00323	0.00323	CcSEcCtD
Metipranolol—Oedema—Doxorubicin—uterine cancer	0.00313	0.00313	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00308	0.00308	CcSEcCtD
Metipranolol—Dyspnoea—Epirubicin—uterine cancer	0.00302	0.00302	CcSEcCtD
Metipranolol—Somnolence—Epirubicin—uterine cancer	0.00301	0.00301	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00285	0.00285	CcSEcCtD
Metipranolol—Dyspnoea—Doxorubicin—uterine cancer	0.00279	0.00279	CcSEcCtD
Metipranolol—Somnolence—Doxorubicin—uterine cancer	0.00278	0.00278	CcSEcCtD
Metipranolol—Hypersensitivity—Epirubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Metipranolol—Asthenia—Epirubicin—uterine cancer	0.00243	0.00243	CcSEcCtD
Metipranolol—Hypersensitivity—Doxorubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Metipranolol—Asthenia—Doxorubicin—uterine cancer	0.00225	0.00225	CcSEcCtD
Metipranolol—Dizziness—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Metipranolol—Rash—Epirubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Metipranolol—Dermatitis—Epirubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Metipranolol—Headache—Epirubicin—uterine cancer	0.00212	0.00212	CcSEcCtD
Metipranolol—Dizziness—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Metipranolol—Nausea—Epirubicin—uterine cancer	0.00201	0.00201	CcSEcCtD
Metipranolol—Rash—Doxorubicin—uterine cancer	0.00197	0.00197	CcSEcCtD
Metipranolol—Dermatitis—Doxorubicin—uterine cancer	0.00197	0.00197	CcSEcCtD
Metipranolol—Headache—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Metipranolol—Nausea—Doxorubicin—uterine cancer	0.00186	0.00186	CcSEcCtD
